Leede Financial analyst Douglas Loe initiated coverage of Satellos Bioscience (Satellos Bioscience Stock Quote, Chart, News, Analysts, Financials TSX:MSCL) on January 28 with a “Speculative Buy” rating and a one-year price target of $2.25, citing the company’s differentiated approach to treating Duchenne muscular dystrophy (DMD) and multiple upcoming clinical catalysts. Satellos is a Toronto-based, clinical-stage biotechnology […]
BNN Bloomberg Market Call guest Colin Cieszynski said Teva Pharmaceutical Industries (Teva Pharmaceutical Industries Stock Quote, Chart, News, Analysts, Financials NYSE:TEVA) has emerged as a standout performer amid a broader rotation into drug stocks, driven by strong price momentum and relative strength rather than company-specific catalysts. Speaking on the Jan. 9 program, the SIA Wealth […]
Share
Tweet
Share
